BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Return 108.35%
This Quarter Return
-0.49%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.95B
AUM Growth
-$162M
Cap. Flow
+$66.5M
Cap. Flow %
2.25%
Top 10 Hldgs %
48.26%
Holding
91
New
14
Increased
7
Reduced
3
Closed
6

Top Buys

1
CGEM icon
Cullinan Oncology
CGEM
$44.8M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$40.2M
3
CNTB
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$38.5M
4
NUVB icon
Nuvation Bio
NUVB
$37M
5
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
$25.4M

Top Sells

1
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$122M
2
PAND
Pandion Therapeutics Inc. Common Stock
PAND
$31.3M
3
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
$25.9M
4
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$21.7M
5
CLDX icon
Celldex Therapeutics
CLDX
$17.5M

Sector Composition

1 Healthcare 96.52%
2 Financials 0.94%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PNT
51
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$15.8M 0.53%
1,500,000
– –
CDAK
52
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$15.5M 0.53%
1,030,065
+427,415
+71% +$6.45M
MIST icon
53
Milestone Pharmaceuticals
MIST
$153M
$14.9M 0.51%
2,572,194
+95,000
+4% +$550K
RNAC icon
54
Cartesian Therapeutics
RNAC
$277M
$14.9M 0.5%
109,469
– –
ESPR icon
55
Esperion Therapeutics
ESPR
$540M
$14M 0.48%
500,000
– –
MTNB icon
56
Matinas BioPharma
MTNB
$9.55M
$12.1M 0.41%
229,573
– –
PSTX
57
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$11.9M 0.41%
1,251,055
– –
BLU
58
DELISTED
BELLUS Health Inc.
BLU
$11.4M 0.39%
2,975,000
– –
AGEN
59
Agenus
AGEN
$138M
$10.9M 0.37%
203,800
– –
ARYD
60
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$10.3M 0.35%
+750,000
New +$10.3M
MEIP icon
61
MEI Pharma
MEIP
$139M
$9.99M 0.34%
145,655
– –
CERE
62
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$9.81M 0.33%
714,500
-600,000
-46% -$8.24M
QURE icon
63
uniQure
QURE
$985M
$8.42M 0.29%
250,000
– –
VINCU
64
DELISTED
Vincerx Pharma, Inc. Unit
VINCU
$8.1M 0.27%
+300,000
New +$8.1M
ASMB icon
65
Assembly Biosciences
ASMB
$183M
$6.9M 0.23%
125,000
– –
MIRM icon
66
Mirum Pharmaceuticals
MIRM
$3.82B
$6.28M 0.21%
317,000
– –
IMMP
67
Immutep
IMMP
$242M
$6.14M 0.21%
+2,000,000
New +$6.14M
KNSA icon
68
Kiniksa Pharmaceuticals
KNSA
$2.65B
$5.38M 0.18%
290,577
– –
BLSA
69
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.29M 0.18%
500,000
– –
RACB
70
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$5.13M 0.17%
+500,000
New +$5.13M
JYAC
71
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$4.92M 0.17%
500,000
– –
ORIC icon
72
Oric Pharmaceuticals
ORIC
$1.06B
$4.9M 0.17%
200,000
– –
OBIO icon
73
Orchestra BioMed
OBIO
$148M
$4.48M 0.15%
400,000
– –
SYRE icon
74
Spyre Therapeutics
SYRE
$1.03B
$4.36M 0.15%
22,000
– –
MLTX icon
75
MoonLake Immunotherapeutics
MLTX
$3.77B
$4.08M 0.14%
400,000
– –
1 2
3
4